A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol.

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.